Secondly, Semaglutide is approved for chronic weight management in adults with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity
While heart palpitations are not listed as a common adverse reaction in FDA prescribing information, semaglutide can increase resting heart rate by 1-4 beats per minute, which some individuals may perceive as palpitations
If you notice alcohol really upsets your stomach now (some patients report they lost the desire to drink because it made them queasy), then just avoid it
Predicted protein structures by AlphaFold and homology modeling must be used for comparison of family members with unknown structures
Read full article: #CVRM #Wegovy #NovoNordisk To view or add a comment, sign in 2,161 followers Explore related topics Trends in Obesity Treatment Options Advancements in Diabetes and Obesity Treatments Trends in Glp-1 Treatment Options Latest Strategies for Diabetes Management Innovations in Diabetes Care and Insulin Management How New Treatments Support Disease Management Latest Developments in Type 1 Diabetes Research Trends in Weight Loss Drug Accessibility Impact of Glp-1 Medications on Health How Glp-1 Drugs Impact Economic Trends
Medications can lose their effectiveness over time, and using expired tirzepatide could impact your treatment outcomes
